29
Participants
Start Date
August 31, 2005
Primary Completion Date
December 31, 2010
Study Completion Date
December 31, 2011
Memantine
Memantine will be given orally. Subjects will be started at a dose of 5 mg for the first week and then increased by 5 mg every week up to a maximum of 20 mg depending on response and tolerance and will be kept at that level for the rest of the study. This is an 8 week study.
Placebo
No active medication, only placebo
Indiana University Adult Psychiatric Clinic, Indianapolis
Indiana University School of Medicine
OTHER